Adaptimmune Therapeutics
ADAP
#9424
Rank
ยฃ45.09 M
Marketcap
ยฃ0.18
Share price
-12.73%
Change (1 day)
-83.73%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -ยฃ51.38 Million

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are ยฃ0.17 Billion. , an increase over its 2023 earnings that were of -ยฃ87.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -ยฃ50.99 Million-41.87%
2023 -ยฃ87.71 Million-30.65%
2022 -ยฃ0.13 Billion-0.36%
2021 -ยฃ0.13 Billion21.62%
2020 -ยฃ0.11 Billion-4.55%
2019 -ยฃ0.11 Billion69%
2018 -ยฃ64.7 Million-7.47%
2017 -ยฃ69.93 Million24.71%
2016 -ยฃ56.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.13 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ5.95 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.2 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ0.53 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA